STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Grant income	$ 462,754	$ 476,556
OPERATING EXPENSES:
Research and development	12,659,287	10,914,531
General & administrative	7,998,573	6,334,271
Total operating expenses	20,657,860	17,248,802
OPERATING LOSS	(20,195,106)	(16,772,246)
Other income	73,022	70,896
Loss on derivative instruments	(760,603)	(8,643,561)
Other non-operating gain (loss)	545,528	(2,276,604)
Interest expense, net	(1,797,481)	(4,215,690)
Net loss	(22,134,640)	(31,837,205)
Modification of warrants		(14,368)
Net loss available to common shareholders	$ (22,134,640)	$ (31,851,573)
NET LOSS PER COMMON SHARE
BASIC	$ (0.71)	$ (1.87)
DILUTED	$ (0.71)	$ (1.87)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	31,174,394	17,004,722
DILUTED	31,174,394	17,004,722